Detection of bcr/abl in SCID Mice at 18 Weeks After Injection
Control | 4/5 (80%) |
CIK cells derived from bone marrow | 1/7 (14.3%)3-150 |
CIK cells derived from peripheral blood | 1/6 (16.7%)3-150 |
Control | 4/5 (80%) |
CIK cells derived from bone marrow | 1/7 (14.3%)3-150 |
CIK cells derived from peripheral blood | 1/6 (16.7%)3-150 |
SCID mice were first injected subcutaneously with low-density CML cells containing 1.5 × 106 CD34+ cells per animal admixed with matrigel. Four weeks later some animals received 4 × 107 autologous CIK cells either derived from bone marrow or peripheral blood. Animals were killed 14 weeks later and analyzed for the presence of bcr/abl transcripts by RT-PCR from RNA extracted from PB, bone marrow, and spleen.
Indicates that the CIK-treated animals were less likely to have positive RT-PCR results (P = .02).